Delivery Order SPE2DB22D2206-SPE2DB25FHP61

Award Date 6/24/25
Potential Completion Date 6/25/25
Potential Value $7.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,086.75 contract is for the supply of BRIVIACT 75 MG TABLET 60S, with an ultimate completion date of October 17, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of BRIVIACT 100 MG TABLET 60S, a prescription medication. The contract has a ceiling value of $2,848.01 and a period of performance through May 1, 2025. It is a firm-fixed-price, non-set-aside contract. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,836.48, is for the supply of BRIVIACT 100 MG TABLET 60S. The contract has a period of performance through June 23, 2025 and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,763.30, is for the supply of the pharmaceutical product BRIVIACT 75 MG TABLET 60S. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BRIVIACT 50 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $2,789.97 and a completion date of May 22, 2025. The contract is a firm fixed-price delivery order, without a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 60 tablets of the medication BRIVIACT 100 MG at a firm fixed price of $1,952.88. The award has a completion date of July 11, 2025 and was issued on July 10, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999.00, which provides a comprehensive global...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRIVIACT 75 MG TABLET 60S, a prescription medication. The order, valued at $2,295.26, is a firm-fixed-price contract with an ultimate completion date of August 6, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of BRIVIACT 50 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $3,723.86 and a period of performance ending on April 19, 2023. The contract is not designated as a set-aside and is under DLA's Troop Support Medical Indefinite Delivery Contract (IDC), a $999,999,999 contract vehicle...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of BRIVIACT 50 MG TABLET 60S. The contract has a ceiling value of $5,458.73 and is a firm fixed-price delivery order agreement with an ultimate completion date of August 9, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract, valued at $4,134.40, is for the supply of BRIVIACT 100 MG TABLET 60S, a prescription medication. The delivery order is a firm fixed-price contract with a completion date of September 6, 2024. This contract award is associated with a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FHP61
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRIVIACT 50 MG TABLET 60S. The contract has a firm fixed price of $7,535.49 and a completion date of June 25, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. The contract is not set-aside and allows for the supply of a wide range of pharmaceutical products and medical supplies to support military and government healthcare programs.

Generated 9/28/25, 1:58 AM